Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

    DATA COMPILATION
    #PharmaFlow

    Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

    Stock Recap
    #PipelineProspector

    Menu

    Impromen

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 419,500Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name MF Registration No. Classification Initial Date of Reg. Latest Date of Reg. Registrant's Address
    31/03/2026 Osaka Synthetic Chemical Laboratories
    Japan
    		 Osaka Synthetic Organic Chemistry Research Institute Co., Ltd. 305MF10052 Bromperidol Manufacturing 2023-04-25 2023-04-25 1-1-2 Nishinomiyahama, Nishinomiya City, Hyogo Prefecture
    31/03/2026 Shiono Finesse
    Japan
    		 Shiono Finesse Co., Ltd. 220MF10075 Bromperidol 2008-03-14 2008-03-14 3-1-6 Doshomachi, Chuo-ku, Osaka City, Osaka Prefecture
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.